BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7680106)

  • 1. The genetic toxicology of putative nongenotoxic carcinogens.
    Jackson MA; Stack HF; Waters MD
    Mutat Res; 1993 Mar; 296(3):241-77. PubMed ID: 7680106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hazard identification: efficiency of short-term tests in identifying germ cell mutagens and putative nongenotoxic carcinogens.
    Waters MD; Stack HF; Jackson MA; Bridges BA
    Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):61-72. PubMed ID: 8143649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic toxicology data in the evaluation of potential human environmental carcinogens.
    Waters MD; Stack HF; Jackson MA
    Mutat Res; 1999 Jul; 437(1):21-49. PubMed ID: 10425388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis.
    Waters MD; Stack HF; Jackson MA; Bridges BA; Adler ID
    Mutat Res; 1994 Dec; 341(2):109-31. PubMed ID: 7527489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Syrian hamster embryo cells transformation assay identifies efficiently nongenotoxic carcinogens, and can contribute to alternative, integrated testing strategies.
    Benigni R; Bossa C; Tcheremenskaia O; Battistelli CL; Giuliani A
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Feb; 779():35-8. PubMed ID: 25813724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
    Osimitz TG; Droege W; Boobis AR; Lake BG
    Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic toxicology of Gene-Tox non-carcinogens.
    Waters MD; Bergman HB; Nesnow S
    Mutat Res; 1988; 205(1-4):139-82. PubMed ID: 3285185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are genotoxic carcinogens more potent than nongenotoxic carcinogens?
    Parodi S; Malacarne D; Romano P; Taningher M
    Environ Health Perspect; 1991 Nov; 95():199-204. PubMed ID: 1821372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxic agents detected by plant bioassays.
    Ma TH; Cabrera GL; Owens E
    Rev Environ Health; 2005; 20(1):1-13. PubMed ID: 15835495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology Program.
    Ashby J; Tennant RW; Zeiger E; Stasiewicz S
    Mutat Res; 1989 Jun; 223(2):73-103. PubMed ID: 2662004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alkaline single cell gel electrophoresis assay with mouse multiple organs: results with 30 aromatic amines evaluated by the IARC and U.S. NTP.
    Sasaki YF; Fujikawa K; Ishida K; Kawamura N; Nishikawa Y; Ohta S; Satoh M; Madarame H; Ueno S; Susa N; Matsusaka N; Tsuda S
    Mutat Res; 1999 Mar; 440(1):1-18. PubMed ID: 10095124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods.
    Waters MD; Jackson M; Lea I
    Mutat Res; 2010 Dec; 705(3):184-200. PubMed ID: 20399889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An approach to identifying specialized batteries of bioassays for specific classes of chemicals: class analysis using mutagenicity and carcinogenicity relationships and phylogenetic concordance and discordance patterns. 1. Composition and analysis of the overall data base. A report of phase II of the U.S. Environmental Protection Agency Gene-Tox Program.
    Ray VA; Kier LD; Kannan KL; Haas RT; Auletta AE; Wassom JS; Nesnow S; Waters MD
    Mutat Res; 1987 May; 185(3):197-241. PubMed ID: 3574331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.
    Butterworth BE
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspects of database construction and interrogation of relevance to the accurate prediction of rodent carcinogenicity and mutagenicity.
    Ashby J
    Environ Health Perspect; 1991 Dec; 96():97-100. PubMed ID: 1820286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetic toxicity of human carcinogens and its implications.
    Shelby MD
    Mutat Res; 1988 Jan; 204(1):3-15. PubMed ID: 3277048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.